ArticleMolecular medicine reports2016

Targeting survivin using a combination of miR‑494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth.

Jin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.